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Abstract 
A simple and straightforward procedure to analyze phosphorylated sphingoid bases has been developed. After phase separation of lipid extracts 
under alkaline conditions, the compounds were quantitatively recovered in the aqueous upper phase. Following a clean-up of the aqueous phase on 
C18-solid phase extraction columns, the amino-group of the bases was derivatized by means of phenylisothiocyanate addition. FAB-MS of the 
phenylthiocarbamate d rivatives of sphingenine- and sphinganine-phosphate in the negative mode revealed the expected pseudo-molecular ions (M-l) 
at 513 m/z and 515 m/z, respectively. Moreover, a typical fragmentation pattern, characterized by the loss of the phenylthiocarbamate moiety 
(m/z = 135), was observed. When applied to rat tissues, the presence of sphingenine-phosphate in brain, kidney and liver could easily be demonstrated. 
Highest levels, amounting to 5 nmol/g of wet weight, were present in brain. 
Key words: Aliphatic amine; Signal transduction; Sphingosine kinase; Sphingenine-phosphate; Sphingosine-phosphatase; 
Sphingosine-phosphate lyase 
1. Introduction 
The involvement of sphingolipids in signal transduc- 
tion has been intensively studied during the last years. In 
addition to ceramide [l], sphingoid bases [2], sphingo- 
sylphosphocholine [3], lysoglycosphingolipids [4], and 
gangliosides [5], sphingosine-phosphate has also been 
added to the list of bioactive sphingolipids. Sphingenine- 
phosphate has been shown to influence the intracellular 
mobilization of calcium [6], to be mitogenic, probably via 
an activation of a phospholipase D activity [7], and to 
inhibit cell motility [8]. The lipid can be formed by phos- 
phorylation of sphingenine [9] (or deacylation of cer- 
amide-phosphate), while attenuation of the signal relies 
on the action of sphingosine-phosphate lyase [lo] and/or 
sphingosine-phosphatase [ 1I]. The presence of phos- 
phorylated sphingoid bases in cells or tissues has sel- 
dom been investigated. Small amounts of 4D-hydroxy- 
sphinganine-phosphate have been found in the intestinal 
mucosa of rats given orally 4D-hydroxysphinganine and 
in the kidney of rats after intravenous administration of 
this sphingoid base [12]. Phosphorylation of the supple- 
mented sphingoid bases has been documented only in 
platelets, which lack sphingosine-phosphate lyase [ 131, 
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and in tissues of rats, given optical isomers of sphin- 
ganine that can be phosphorylated but not cleaved [14]. 
Very recently, the transient formation of labeled sphin- 
genine-phosphate in Swiss 3T3 cells, grown in the pres- 
ence of labeled serine, in response to PDGF and serum 
has been reported [ 151. To our knowledge, no reports on 
the quantification of phosphorylated sphingoid bases in 
biological systems have appeared. Using tritiated sphin- 
ganine-phosphate, we were able to investigate the behav- 
ior of these zwitterionic lipids during phase extraction 
and to develop an analytical method based on mass spec- 
trometry of the phenylthiocarbamate derivatives. 
2. Materials and methods 
2.1. Materials 
Sphingolipids were obtained from Sigma, St. Louis, MO, USA. 
Sphingenine-phosphate [16], sphinganine-phosphate [16], [4,5- 
‘Hlsphinganine-phosphate [II, I-alk(en)ylphosphoethanolamine [l I] 
were prepared as described. PITC and 4-biphenylcarbonylchloride 
were purchased from Aldrich, Bomem, Belgium and triethylamine and 
pyridine, both sequencing rade, from Pierce Europe, Oud Beijerland, 
the Netherlands. Solid phase extraction columns (Cl8 Bond Elut - 100 
mg) were from Analytichem International, Harbor City, California, 
USA. 
2.2. Lipid extraction and derivatisation 
Fresh tissues (1 g of wet weight), obtained from male Wistar rats, 
were rinsed in cold physiological salt solution, patted dry and cut into 
smaller pieces and homogenized by means of a Polytron homogenizer 
in 3 ml of methanol/chloroform (2: 1 v/v). In order to check the recov- 
eries of phosphorylated sphingoid bases during the work-up, a dupli- 
cate was spiked with 2 nmol of [4,5-3H]sphinganine-phosphate (94550 
dpm). After extraction of the lipids for 30 min, denatured proteins were 
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removed by centrifugation. The pellet was reextracted by adding 0.8 ml 
of water and 3 ml of methanol/chloroform (2 : 1 v/v). The latter step was 
repeated twice. The combined extracts, containing approximately 99% 
of the added radioactivity, were phase separated by adding 4 ml of 
chloroform and 4 ml of 0.1 M NH,OH. After centrifugation, the upper 
phase was removed and the lower phase was washed once with 8 ml of 
0.1 M NH,OH/methanol (6 : 2 v/v). The combined yellowish alkaline 
upper phases, which contained 90% to 95% of the extracted radioactiv- 
ity, were reduced in volume to approx. 5 ml by a gentle stream of dry 
nitrogen at 45°C diluted two-fold with 0.1 M NH,OH (in order to 
reduce their content of remaining methanol) and then applied to acti- 
vated Cl&SPE cartridges. Tubes were rinsed with 2 x 3 ml of 0.1 M 
NH,OH and rinses were also applied to the SPE-cartridges which were 
subsequently washed with 10 ml of 0.1 M NH,OH. Depending on the 
tissue, 5% to 10% of the radioactivity present in the alkaline aqueous 
upper phases did not bind to the reversed phase. Following an interme- 
diate wash with 4 ml of 0. I M NH,OH in 35% (v/v) methanol in which 
almost no radioactivity was present, phosphorylated sphingoid bases 
were eluted with 8 ml of 0.1 M NH,OH in 80% (v/v) methanol. The 
eluate was dried under nitrogen, dissolved in 0.1 ml of ethanol/pyridine/ 
triethylaminelwater (6: 1: I : 2 v/v) and derivatized by adding IO ~1 of 
PITC. For the derivatization of standards, volumes were reduced two- 
fold and lipids were first redried from 50 ~1 of ethanol/pyridine/trieth- 
ylamine/water (6 : 1 : 1: 2). Reactions were allowed to proceed at room 
temperature for 40 min and the mixtures were dried under nitrogen and 
redried once from methanol. In case of tissue extracts, the derivatized 
extracts were subjected to an additional phase separation. After dissolv- 
ing the yellow extracts in 3.8 ml of methanol/chloroform/water 
(2: I : 0.8) phase separation was induced with 1 ml of chloroform and 
1 ml of 0.25 M acetic acid. After an additional wash with 2 ml of 
theoretical upper phase, the lower phase containing 90% of the deriva- 
tive was dried under nitrogen and stored at -20°C until analysis. 
2.3. Mass-spectrometry 
Derivatized standards and tissue extracts were dissolved in a 20 .uI 
of methanol and approx. 0.5 ~1 was mixed with a drop of glycerol, 
placed at the tip of the probe. FAB-MS was performed with a Finnigan 
MAT TSQ 70 triple quadrupole mass spectrometer equipped with an 
Ion Tech FAB gun operated at 6 kV. For the tandem mass spectrometry 
experiments, Xe at 0.8 mTorr was used as the collision gas. The collision 
energy was 10 eV. 
3. Results and discussion 
The analysis of phosphorylated sphingoid bases in bi- 
ological samples as described in this paper relies on three 
steps: (1) a selective, non-destructive xtraction; (2) a 
selective, mild derivatisation; (3) mass characterization 
of the derivatized compound. Phosphorylated sphingoid 
bases are known to be poorly soluble in organic and 
aqueous solvents (see [lo]). The distribution of pmolar 
solutions between organic and aqueous phases of the 
classical Folch [18] or Bligh-Dyer [19] extractions ap- 
peared to be governed mainly by the phosphate moiety. 
For tritiated sphinganine-phosphate, recoveries in the 
aqueous upper phase during acidic (0.1 M HCl), neutral 
and high ionic strength (1 M NaCl), and alkaline (0.1 M 
NaOH) conditions were 22%, 45% and lOO%, respec- 
tively (in the absence of exogenous lipids). Recoveries of 
[4,5-3H]sphinganine on the other hand were almost not 
influenced by the pH (being 90%, 95% and lOO%, respec- 
tively, in the lower phases of the above mentioned extrac- 
tion systems). Hence, an alkaline phase separation was 
chosen as starting step. In order to minimize the amount 
of sodium-ions which interfere with the mass spectrome- 
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Fig. 1. Mass spectra of PTC-derivatives of sphingenine-phosphate. In 
panel A, the FAB-spectrum of sphingenine-phosphate (150 nmol of 
starting product), after derivatisation with PITC, is shown. The corre- 
sponding daughter spectra in the negative and positive mode are shown 
in panel B and C, respectively. In the fragmentation pattern inserted 
in panel A, the size of the molecular pseudo-ions, expected to be seen 
in the positive mode, are written in italic numbers. 
try of the final preparations, 0.1 M NH,OH was used. 
Extraction conditions are sufficiently mild to avoid 
hydrolysis of N-acylated sphingolipids and to limit the 
hydrolysis of 1 -alk(en)yl-2-acylglycerophosphoethanol- 
amine. The latter compounds would give rise to 
l-alk(en)yl-glycerophosphoethanolamine, th  behavior of 
which during phase separation and thin layer chroma- 
tography resembles that of phosphorylated sphingoid 
bases ([ll]; Van Veldhoven, P.P. and Mannaerts, G.P., 
unpublished data), and which is also derivatized by our 
procedures (see below). 
Binding of the phosphorylated sphingoid bases to the 
Cl &phase appeared not to be controlled by pH. Almost 
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Fig. 2. Mass spectra of PTC-derivatives of rat tissue extracts. Mass spectra of extracts of rat brain (A), rat kidney (B), and rat liver (C), prepared 
and derivatized with PTC as described in the method section, were analysed for the loss of the PTC-moiety in the negative mode (-NLOSS = 135). 
In panel D, the corresponding spectrum for 1.6 nmol of sphingenine-phosphate + 0.4 nmol of sphinganine-phosphate standard, carried throughout 
the extraction procedure, is shown. 
complete binding was observed whether the bases were 
applied in 0.1 M HCl, 0.1 M ammonium acetate, pH 7.0, 
or 0.1 M NH,OH (although solubility is lower in neutral 
and acidic solvents). Hence, the alkaline upper phases, 
after reducing their methanol content, could be directly 
applied to the Cl 8 columns. In addition, we did not have 
to fear precipitation of the phosphorylated sphingoid 
bases at neutral or acidic pH. Elution from the reversed 
phase occurred between 50 and 70% (v/v) methanol, ei- 
ther under acidic or alkaline conditions. Although the 
alkaline nature of the eluent might cause some damage 
to the matrix during long-term use, we adhered to the 
described protocol, since in this way the aminogroup of 
the sphingoid bases was in the appropriate unprotonated 
form for the derivatization. 
For the derivatization an agent compatible with the 
following criteria was chosen: (1) selectivity for the pri- 
mary amino group and no reactivity towards amides 
and, preferentially, secondary amines; (2) mild derivati- 
zation conditions to avoid formation of any sphingosine- 
phosphate by hydrolysis of N-acylated sphingolipids 
such as ceramide-phosphate or sphingomyelin (although 
their presence in the extracts is unlikely) or from sphin- 
gosylphosphocholine (a compound more likely to be 
present in the extracts); (3) stability of the derivative. 
Therefore, the formation of biphenylcarbonyl deriva- 
tives and of phenylthiocarbamates was investigated. 
Biphenylcarbonylchloride has already been used to deri- 
vatize sphingosylphosphocholine and psychosine [20], 
followed by HPLC separation and detection at 280 nm. 
In our hands, however, the biphasic nature of the reac- 
tion caused problems, and during the work-up of the 
samples, a considerable amount of the derivative was 
lost. With PITC, a complete conversion was obtained as 
monitored by TLC (data not shown). The volatility of 
the reaction mixture and reagent is an additional advan- 
tage. Moreover, a specific fragmentation pattern could 
be obtained with these derivatives, not only for sphingen- 
ine-phosphate (see below), but also for other lysosphin- 
golipids (unpublished data). 
With glycerol as the matrix, excellent and clean FAB- 
mass spectra were obtained in the negative mode clearly 
showing the expected pseudo-molecular ion (M- 1) of 5 13 
m/z for sphingenine-phosphate (Fig. 1A). Analysis of 
sphinganine-phosphate-PTC showed a pseudo-molecu- 
lar ion of 51 S m/z (data not shown). For both com- 
pounds, the most abundant fragment (378 m/z and 380 
m/z, respectively) corresponded to the loss of the PTC- 
moiety (m/z = 135). Also the fragmentation of the parent 
pseudo-molecular ion was consistent with their proposed 
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structure (Fig. 1B and C). As expected, in the positive 
mode, fragments containing the phosphate-group were 
not recorded, but the typical W’ (m/z 282) and W’ (m/z 
264) ions [21] were seen. 
When biological extracts were examined via FAB-MS 
for those compounds which had lost the PTC-moiety 
(-NLOSS = 135) the profiles for liver, kidney and brain 
were quite different (Fig. 2). In brain, the most intense 
molecular ion (5 13 m/z) corresponded to that of sphin- 
genine-phosphate-PTC (Fig. 2A). Also in kidney, the 
presence of sphingenine-phosphate was evident (Fig. 
2B). In liver, the 513 m/z peak was just above noise level 
(Fig. 2C). By daughter analysis the pseudo-molecular ion 
at 513 m/z in liver extracts was verified to be due to 
sphingenine-phosphate-PTC. Most of the other molecu- 
lar ions, seen in liver and kidney extracts, could be iden- 
tified as monoesterified glycerophosphoethanolamine- 
PTC derivatives containing palmitoyl (M-l = 587) or 
oleoyl (M-l = 613) as acyl chain. In brain almost no 
ester-compounds were observed, but the presence 
of alkenylglycerophosphoethanolamine-PTC deriva- 
tives was very prominent (palmityl: M-l = 571; stearyl: 
M-l = 599). 
With the exception of liver in which the 515 and 513 
pseudo-molecular ion peaks were of similar intensity, the 
presence of sphinganine-phosphate could not be demon- 
strated in kidney and brain. In kidney and even more 
pronounced in brain, a pseudo-molecular ion at 541 m/z 
was observed which corresponded to the C,,-sphingen- 
ine-phosphate-PTC derivative. 
Presently, we are considering the synthesis of some 
analogue which can be used as an internal standard for 
the quantitation of phosphorylated sphingoid bases. Due 
to the rather high molecular mass of the investigated 
compounds resulting in additional molecular ion peaks, 
[4,5-2D]sphinganine-phosphate (M-l of PTC-derivative 
of 5 17 m/z) does not seem to be a good choice, but 
sphinganine-phosphonate (M-l of PTC-derivative of 499 
m/z), first synthesized by Stoffel and Grol [22], might be 
a good candidate. Nevertheless, a rough estimation was 
obtained by spiking a duplicate biological extract with 
2 nmoles of phosphorylated bases (1.6 nmol of sphinge- 
nine-phosphate plus 0.4 nmol of sphinganine-phosphate) 
and normalising the intensities of the m/z 513 peaks to 
that of other prominent peaks, representing one of the 
acyl- or alk(en)ylglycerophosphoethanolamines-deriva- 
tives. Concentration of sphingenine-phosphate in liver, 
kidney and brain are estimated at 0.2-0.3 nmol, 0.5-0.8 
nmol and 3.5-5 nmol/g of wet tissue, respectively. Simi- 
lar values were obtained by comparing the relative inten- 
sities of the reaction side products, diphenylthiourea (m/ 
z 228) and ethylamine-PTC (m/z 180), seen in the biolog- 
ical samples and in a standard containing a 1.6 nmol of 
sphingenine-phosphate plus 0.4 nmoles of sphinganine- 
phosphate and carried through the whole procedure 
(Fig. 2D), with the intensity of the m/z 513 ion. Although 
these values are approximate, it is remarkable that they 
are in the same range as the sphingenine concentration 
reported in rat and mouse tissues [23,24]. 
Combined with our previous work on the turnover of 
exogenously added sphinganine-phosphate o cultured 
fibroblasts [l l] and that of other groups on the bioactiv- 
ity of sphingenine-phosphate [68] and its generation in 
response to growth factors [15], these new data certainly 
favor a role of sphingenine-phosphate as a biomodula- 
tor. In this respect, the high sphingenine-phosphate 
content of brain might deserve special attention. In a 
previous paper [I l] we proposed that sphingosine-phos- 
phatase and sphingosine-phosphate lyase are involved in 
the attenuation of bioactive sphingenine-phosphate and 
the catabolic removal of this lipid, respectively. Prelimi- 
nary data indicate that the sphingenine-phosphate levels, 
as reported above, correlate better with the phosphatase 
activities (expressed on a weight basis), being 5- to 6-fold 
higher in brain (and other neuronal tissues) than in liver 
(De Ceuster, P., Mannaerts, G.P. and Van Veldhoven, 
P.P., unpublished data), than with the lyase activities 
which are approx. 4-fold lower in brain than in liver [lo]. 
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